Tower Research Capital (TRC)’s Alvotech ALVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.1K Buy
5,288
+1,943
+58% +$8.54K ﹤0.01% 3546
2025
Q4
$17.2K Sell
3,345
-2,831
-46% -$17.9K ﹤0.01% 3217
2025
Q3
$50.6K Buy
6,176
+4,263
+223% +$36.3K ﹤0.01% 2522
2025
Q2
$17.4K Sell
1,913
-6,414
-77% -$60.2K ﹤0.01% 3752
2025
Q1
$80.5K Buy
8,327
+7,366
+766% +$89.4K ﹤0.01% 1891
2024
Q4
$12.7K Buy
+961
New +$11.8K ﹤0.01% 3591
2022
Q4
Sell
-1,003
Closed -$7K 5849
2022
Q3
$7K Sell
1,003
-1,484
-60% -$11.5K ﹤0.01% 4861
2022
Q2
$20K Buy
+2,487
New +$23.1K ﹤0.01% 3776

Other funds holding ALVO

Tower Research Capital (TRC)'s ALVO Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Alvotech (ALVO) stake by 58% in Q1 2026, buying an estimated $8.54K and bringing the position to 5,288 shares worth $18.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3546.

Tower Research Capital (TRC) first reported a position in ALVO in Q2 2022 and has held it in 8 quarters since. The position peaked at $80.5K in Q1 2025. 57 funds tracked by Wall St. Rank hold ALVO as of Q1 2026.

  • Tower Research Capital (TRC) held 5,288 shares of Alvotech worth $18.1K as of Q1 2026.
  • Tower Research Capital (TRC) bought 1,943 Alvotech shares in Q1 2026, an estimated $8.54K.
  • Alvotech made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3546 holding.
  • Tower Research Capital (TRC) first reported a position in Alvotech in Q2 2022 and has held it in 8 quarters since.
  • Tower Research Capital (TRC)'s Alvotech position peaked at $80.5K in Q1 2025.
  • 57 funds tracked by Wall St. Rank held Alvotech as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.